Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-16

Clinical Trial Update: Prognosis Value of the Neuronal Damage in Early Multiple Sclerosis [NA]

View source ↗

Summary

A clinical trial update investigating the prognostic value of neuronal damage in early multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Multiple Sclerosis | NA | Status: UNKNOWN